Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-08

Clinical Trial Update: A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis

View source ↗

Summary

This completed clinical study investigates how liver cirrhosis alters the pharmacokinetics of ceftriaxone in patients. The aim is to inform dosing adjustments i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Antibiotic Toxicity, Liver Cirrhosis | Status: COMPLETED